Picture of Chitogenx logo

CHGX Chitogenx Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Chitogenx, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.

2020
January 31st
2021
January 31st
2022
January 31st
2023
January 31st
2024
January 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-2.49-3.77-4.92-6.23-1.55
Depreciation
Non-Cash Items0.7821.451.261.52-1.21
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.003-0.7520.3681.461.71
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-1.59-2.98-3.22-3.2-1.01
Capital Expenditures0-0.003-0.0330
Purchase of Fixed Assets
Cash from Investing Activities0-0.003-0.0330
Financing Cash Flow Items-0.077-0.1730.0740.6180
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.375.051.162.940.937
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.2222.08-2.07-0.205-0.073